Canada
USA
UK
IntelliRisk™ enables healthcare providers to assess, identify, and manage high risk patients efficiently and effectively. By incorporating established clinical guidelines, advanced short-term and long-term breast cancer risk models, and best practices, it supports informed decision-making across the entire breast health pathway.
Provides precise, individualized life-time breast cancer risk assessments, supporting treatment plans that are tailored to each patient’s unique risk profile.
Supports healthcare providers in meeting clinical guidelines by offering a structured approach to identify, monitor, and document high-risk patients, aligning with national standards for cancer care.
Streamlined data integration enables rapid access to comprehensive risk insights, allowing for faster, more coordinated decision-making in patient management.
Prioritizes proactive management of high-risk patients to optimize resource allocation, contributing to sustainable practices that focus on prevention and targeted surveillance over time.
Healthcare leaders across the spectrum – service line managers, CMOs, CIOs, large health systems, Integrated Delivery Network, and private radiology groups – are increasingly recognizing the pivotal role of high-risk breast cancer clinics. Once considered a niche concept, these specialized programs are quickly becoming a standard component of comprehensive breast care. The big question for administrators and executives is clear: How do high-risk clinics financially justify themselves while improving patient outcomes?
Densitas delivers integrated image quality assurance and risk stratification to support high-risk clinic pathways. Read our latest blog to learn more.
